Business News: Incyte Appoints Dr. Dashyant Dhanak as Chief Scientific Officer

27Nov - by Editor - 0 - In STL.News



WILMINGTON, DE – Incyte (NASDAQ:INCY) today announced the appointment of Dashyant Dhanak, Ph.D. as Executive Vice President and Chief Scientific Officer, effective December 10, 2018.  Dr. Dhanak will succeed Dr. Reid Huber, who has been at Incyte since 2002 and is leaving the Company to pursue opportunities in the early-stage life sciences community.

“Reid’s contributions to Incyte have been instrumental in its evolution from a start-up operation to the world-class discovery engine of today, and I thank him most sincerely for his commitment and critical thinking over the last 16 years,” said Hervé Hoppenot,  Chief Executive Officer, Incyte. 

Continue reading Business News: Incyte Appoints Dr. Dashyant Dhanak as Chief Scientific Officer at STL.News.



Source link